Defining a metrologically traceable and sustainable calibration hierarchy of International Normalized Ratio (INR) for monitoring of vitamin K antagonist treatment in accordance with International Standard ISO 17511:2020: Communication from the IFCC-SSC/ISTH working group on PT/INR standardization.

Anticoagulants Calibration International Normalized Ratio Metrological Traceability Prothrombin Time Thromboplastin

Journal

Journal of thrombosis and haemostasis : JTH
ISSN: 1538-7836
Titre abrégé: J Thromb Haemost
Pays: England
ID NLM: 101170508

Informations de publication

Date de publication:
19 Dec 2023
Historique:
received: 18 09 2023
revised: 01 12 2023
accepted: 07 12 2023
medline: 22 12 2023
pubmed: 22 12 2023
entrez: 21 12 2023
Statut: aheadofprint

Résumé

Calibration of Prothrombin Time (PT) in terms of the International Normalized Ratio (INR) has been outlined in 'Guidelines for thromboplastins and plasmas used to control oral anticoagulant therapy' (World Health Organization, 2013). International Standard ISO 17511:2020 presents requirements for manufacturers of In-vitro Diagnostic Medical Devices (IVD MD) in documenting the calibration hierarchy for a measured quantity in human samples using a specified IVD MD. The objective of this article is to define an unequivocal, metrologically traceable calibration hierarchy for the INR measured in plasma as well as in whole blood samples. Calibration of PT and INR for IVD MD according to WHO Guidelines is similar to cases where there is a reference measurement procedure that defines the measurand for value assignment as described in ISO 17511:2020. We conclude that for PT/INR standardization the optimal calibration hierarchy includes a primary process to prepare an international reference reagent and measurement procedure that defines the measurand by a value assignment protocol conforming to clause 5.3 in ISO 17511:2020. A panel of freshly prepared human plasma samples from healthy adult individuals and patients on vitamin K antagonists is used as a commutable secondary calibrator as described in ISO 17511:2020. A sustainable metrologically traceable calibration hierarchy for INR should be based on an international protocol for value assignment with a single primary reference thromboplastin and the harmonized manual tilt tube technique for clotting time determination. The primary international reference thromboplastin reagent should be used only for calibration of successive batches of secondary reference thromboplastin reagent.

Identifiants

pubmed: 38128762
pii: S1538-7836(23)00911-X
doi: 10.1016/j.jtha.2023.12.013
pii:
doi:

Types de publication

Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Antonius M H P van den Besselaar (AMHP)

Coagulation Reference Laboratory, Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands,. Electronic address: a.m.h.p.van_den_besselaar@lumc.nl.

Anne Stavelin (A)

The Norwegian Organisation for Quality Improvement of Laboratory Examinations, Bergen, Norway.

Steve Kitchen (S)

Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK.

Michelle Bryant (M)

Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK.

Armando Tripodi (A)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano and Fondazione Luigi Villa, Milano, Italy.

Erica Scalambrino (E)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano and Fondazione Luigi Villa, Milano, Italy.

Marigrazia Clerici (M)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano and Fondazione Luigi Villa, Milano, Italy.

Petra Herbel (P)

Roche Diagnostics GmbH, Mannheim, Germany.

Anja Jünschke (A)

Roche Diagnostics GmbH, Mannheim, Germany.

Sascha Meyer Dos Santos (S)

Roche Diagnostics GmbH, Mannheim, Germany.

Piet Meijer (P)

ECAT Foundation, Voorschoten, the Netherlands.

René W L M Niessen (RWLM)

Federation of Dutch Thrombosis Services, Leiden, the Netherlands.

Joost C M Meijers (JCM)

Department of Molecular Hematology, Sanquin Research, Amsterdam, and Amsterdam UMC, University of Amsterdam, Department of Experimental Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.

Craig Thelwell (C)

Therapeutic Reference Materials, Medicines and Healthcare Products Regulatory Agency, National Institute for Biological Standards and Control, Potters Bar, UK.

Adam Cuker (A)

Department of Medicine and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Chun Kung (C)

Werfen, Orangeburg, New York, USA.

Zhenghua Cao (Z)

Werfen, Orangeburg, New York, USA.

Norbert Zander (N)

Siemens Healthineers, Marburg, Germany.

Yosuke Iwasaki (Y)

Sysmex Corporation, Kobe, Japan.

François Depasse (F)

Diagnostica Stago, Asnières-sur-Seine, France.

Claudia van Rijn (C)

Coagulation Reference Laboratory, Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.

Shanti Baktawar (S)

Coagulation Reference Laboratory, Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.

Charmane Abdoel (C)

Coagulation Reference Laboratory, Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.

Christa M Cobbaert (CM)

Coagulation Reference Laboratory, Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.

Classifications MeSH